Tianeptine sodium salt

CAS Number 30123-17-2
Molecular Formula C₂₁H₂₄ClN₂NaO₄S
Molecular Weight 458.9 g/mol
Purity ≥99.5%
Appearance White powder

Founded in 2017, Sigma Chemical Co., Ltd. supplies over 100 countries with high-quality chemicals. We are dedicated to safety, innovation, and global cooperation.

Product Description

Tianeptine sodium, also known as tianeptine sodium salt, is an atypical tricyclic antidepressant with a unique mechanism of action. Unlike traditional SSRIs, it enhances serotonin reuptake and modulates glutamate receptor activity, offering neuroprotective, anxiolytic, and antidepressant properties. Structurally, it is a modified tricyclic compound with enhanced water solubility due to its sodium salt form. It is approved in some countries, such as France and Russia, for treating major depressive disorder, with a typical dosage of 12.5 mg three times daily. However, it is not approved by the FDA in the U.S. due to concerns about its potential for abuse and opioid-like dependence, especially at high doses. Misuse can lead to severe adverse effects, including neurological, cardiovascular, and gastrointestinal symptoms, and withdrawal can cause significant distress.

Synthesis Methods

  • Patented Synthesis: Originally patented by Malen et al. at the French Society of Medical Research in 1973.

  • Commercial Synthesis: The patent for the synthesis of tianeptine was issued to Biophore India Pharmaceuticals in 2010.

Analytical Methods

  • Spectrophotometry: A simple, sensitive, and cost-effective extraction visible spectrophotometric method has been developed for the determination of tianeptine sodium in bulk and tablet dosage forms. The method involves the formation of a colored ion-association complex with Tropaelin OOO (orange dye II) in an acid medium, with an absorption maximum of 489 nm.

  • HPLC: High-performance liquid chromatography (HPLC) methods have been reported for the determination of tianeptine sodium in biological fluids and formulations.

  • Other Methods: Other analytical techniques include potentiometric titration, flow injection analysis, spectrofluorometry, voltametry, and gas chromatography (GC).

Common Applications

  • Medical Uses:

    • Antidepressant: Tianeptine sodium salt is primarily used as an atypical antidepressant.

    • Anxiolytic: It has anxiolytic properties, helping to reduce anxiety.

    • Neuroprotective: Exhibits neuroprotective effects.

    • Anti-ulcer and Anti-emetic: Demonstrates anti-ulcer and anti-emetic properties.

    • Psycho-stimulant: Acts as a psycho-stimulant.

    • Mood-brightening: Enhances mood.

  • Research Uses:

    • Anti-invasive Agent: Studies suggest that tianeptine sodium salt can suppress tumor invasion by reducing the expression of matrix metalloproteinase-9 (MMP-9) via inhibition of the PI3K/Akt-mediated NF-κB pathway.

    • Serotonin Reuptake Enhancer: Acts as a selective facilitator of serotonin reuptake, enhancing presynaptic reuptake of serotonin without affecting noradrenaline or dopamine uptake.

Properties

  • Molecular Formula: C₂₁H₂₄ClN₂NaO₄S

  • Molecular Weight: 458.9 g/mol

  • IUPAC Name: Sodium;7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoate

  • Chemical Structure: Tianeptine sodium salt is a tricyclic compound with a dibenzothiazepine core and a heptanoic acid side chain. It contains a chlorine atom and a sodium ion associated with the sulfonate group.

  • Solubility: Freely soluble in water, methanol, and methylene chloride.

  • Isomers: Exists as two isomers, with the levorotatory isomer being the therapeutically active form.

  • Metabolism: Primarily metabolized via β-oxidation of its heptanoic side chain, with major metabolites being pentanoic (MC5) and propionic (MC3) acid side chain derivatives found in urine and plasma.

Regulatory and Safety Information

  • FDA Status: Not approved by the U.S. Food and Drug Administration (FDA) for medical use in the United States due to concerns about its potential for abuse and dependence.

  • Controlled Substance: Classified as a Schedule II controlled substance in some U.S. states (e.g., Michigan, Alabama, Minnesota, Tennessee, and Oklahoma).

  • Side Effects: Common side effects include nausea, dizziness, constipation, and risk of dependence at supratherapeutic doses.

  • Withdrawal Symptoms: Severe withdrawal symptoms can occur, including agitation, depression, muscle pain, chills, and sweating.

Environmental and Toxicological Information

  • Anti-invasive Effects: Tianeptine sodium salt has been shown to reduce the invasive potential of tumor cells by suppressing the expression of MMP-9 via the PI3K/Akt-mediated NF-κB pathway.

  • Carcinoma Cell Studies: Studies have demonstrated that tianeptine sodium salt can significantly attenuate invasive rates in TNF-α-stimulated carcinoma cells, suggesting its potential as an anti-invasive agent in cancer treatment.

Product Inquiry

Please enter your full name
Please enter your company name
Please enter a valid email address
Please select quantity
Please enter your inquiry